Encompass Compliance ENCC · USD

Market value

$1.6m

Last close × shares

Volume

79.3k

Shares, 9 Nov 2026

Its shares trade under the ticker ENCC. It has been listed since 13 March 2000. In the fiscal year to 31 December 2019, it reported revenue of $367,399 and a net loss of $290,798. At that date it held total assets of $16,146 and shareholders' equity of −$291,764.

Encompass Compliance Corp. engages in the provision of workplace drug and alcohol testing compliance services. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2000-03-13. The firm offers an annual subscription service, which maintains compliance and updates employers on the impact of the law, to their workplace. Its services include statutes, regulations, court decisions and the Drug Testing Compliance Matrix, which provides the guidance for managing the rules that apply. The company focuses on Medical Marijuana, Opiates, Synthetics, as well as other drugs and alcohol usage in the workplace. The firm also offers training modules, consulting on the implementation of this service, and training tools, as well as Claims defense services to its customers. Its solutions provide organizations with up-to-date policies, a resource center and real-time monitoring for drug and alcohol testing orders. The firm offers Risk Shield, which allows employers to create a core drug and alcohol policy and accounts for all regulations.

Figures and description from our data supplier, not checked against the company's own report.

More about Encompass Compliance →

• ENCOMPASS CORPORATION INTEGRATES WITH DOW JONES RISK & COMPLIANCE 22 Jul 2017

Leaves out fees, taxes and financing.

Chart

TradingView

Close and company data

Our data supplier

News

Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.